NEWS RELEASE: DuPont Expands Healthcare Manufacturing Site in Costa Rica, Adding Sterile Packaging Capacity
The 16,000-square-foot expansion enhances DuPont’s global sterile operations, increases the capacity of the manufacturing site’s existing medical tubing operations, and enables Costa Rica’s first-ever production of sterile healthcare packaging.
Wilmington, Delaware – DuPont (NYSE:DD) today announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica, enabling the site to produce sterile packaging for the global medical device industry while also increasing the capacity of the site’s existing medical tubing operations.
To serve Healthcare customers in the Caribbean and more broadly across the Americas, the Heredia operation has expanded by 16,000 square feet. The new space accommodates additional extrusion equipment and production lines, enabling production of sterile packaging leveraging Tyvek® – such as pouches, header bags and lids – and increasing DuPont’s extruded tubing production capacity.
The new expansion is ISO 13485:2016 and ISO 9001:2015 certified, with its technical, assembly and packaging staff adhering to the highest quality standards and protocols. To support current and new customers, the facility is operating on a 24/7 production schedule.
“With this expansion, we are now the first company in Costa Rica and the Caribbean to produce fluid management and sterile packaging offerings for the medical device industry,” said James Chambers, Senior Vice President and General Manager for Fluids & Flexibles at Spectrum Plastics Group, A DuPont Business. “This significantly enhances our robust, growing portfolio of unmatched offerings and capabilities as a trusted supply chain partner to leading global healthcare companies.”
DuPont’s products, services and expertise for the healthcare industry include extruded tubing and subassemblies, advanced catheter assembly, medical balloons, skin contact devices, smart wearables, additive manufacturing, laser processing, precision injection-molding, medical device fabrication, machining and sterile packaging enabled by Tyvek®.
Combining medical-grade performance materials, component and device solutions, and innovative technology, DuPont offers full-service, comprehensive solutions that support a range of healthcare applications. Learn more about DuPont’s healthcare solutions at healthcare.dupont.com.
About Spectrum Plastics Group, A DuPont Business
Acquired by DuPont in August 2023, Spectrum Plastics Group, A DuPont Business, brings over 60 years of expertise in advanced polymer processing and medical device manufacturing. The company specializes in precision extrusion, specialty injection molding, blown film extrusion and conversion, medical balloon fabrication, laser processing, additive manufacturing, and complex catheter and device assembly. Spectrum is recognized as a leading trusted supplier for the development and production manufacturing of critical polymer-based components and finished devices for the medical device market and other high-performance applications. With global facilities and more than 1 million square feet of manufacturing space, Spectrum delivers proven quality, innovation and technical excellence to solve the most demanding customer challenges. The company supports a broad range of healthcare applications across the biopharmaceutical processing, medical device and pharmaceutical markets. More information can be found at spectrumplastics.com.
About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
